查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1886172

数位生物製造市场规模、占有率、预测及趋势分析：按产品（软体/硬体）、功能（产品设计、分析、自动化）、应用（单株抗体、蛋白质、疫苗）和生物製程划分－全球预测至2035年

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software Hardware), Functionality (Product Design, Analytics, Automation), Applicatison (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2035
出版日期: | 出版商: Meticulous Research | 英文 226 Pages | 订单完成后即时交付

价格

预计2025年至2035年，数位生物製造市场将以12.6%的复合年增长率成长，到2035年达到764亿美元。本报告对五大主要地区的数位生物製造市场进行了详细分析，重点关注当前市场趋势、市场规模、近期发展以及至2035年的预测。

基于广泛的二级和一级研究以及对市场现状的详细分析，本报告对关键行业驱动因素、限制因素、机会和挑战的影响进行了分析。此市场成长的驱动因素包括：对生物製药的需求不断增长、大型企业扩大生物製药厂产能、对连续生物製程的日益重视、生物製造製程优化需求的不断增长，以及对品质标准和法规遵从性的日益重视。此外，人工智慧 (AI) 和机器学习的融合、基于云端的製造平台、数位孪生技术的应用以及向生物工艺 4.0 的转型，预计也将支持市场成长。

然而，仍有许多挑战，包括技术采用成本高昂、生物製药的研发和生产流程复杂、与传统系统整合方面的挑战，以及对资料安全和智慧财产权保护的担忧。

数位生物製造市场按产品（软体和硬体）、功能（产品设计、流程优化和分析、自动化和控制、即时品质监控和合规性、供应炼和营运管理以及其他功能）、生物製程（上游和下游生物製程）、应用（单株抗体、重组荷尔蒙/蛋白、疫苗、细胞生物製剂、基因生物製剂、生物相似药、工业生物技术以及其他应用）、最终用户（生物製药公司、学术和研究机构、CDMO/CRO、食品和工业生物技术公司以及其他最终用户）和地区进行细分。本研究也评估了产业竞争对手，并提供了国家层面的市场分析。

预计到 2025 年，软体领域将占最大的市场占有率，达到 58%。该领域的主导地位主要归功于其作为核心智慧层的基础性作用，它驱动着所有生物製造流程的流程优化、数据分析和即时决策。这些软体包括先进的製程分析技术 (PAT) 系统、先进的数据分析软体、製造执行系统 (MES) 以及能够创建生物製程操作虚拟副本的尖端数位孪生平台。此外，嵌入这些平台的人工智慧 (AI) 和机器学习功能的持续发展也推动了该领域的成长。我们看到，简单的监控系统正在转变为能够进行预测分析、自主流程调整和认知决策的智慧平台。在预测期内，受云端解决方案和高阶分析技术日益普及的推动，软体领域也预计将显着成长。

预计到2025年，製程优化和分析领域将引领数位生物製造市场。该领域的领先地位反映了生物製造製程持续改进的重要性，即使是微小的最佳化也能显着降低成本、提高产量和品质。製程优化和分析包括先进的统计製程控制、实验设计 (DoE)、多元数据分析以及基于机器学习的最佳化演算法，这些技术能够持续分析製程参数并识别改进机会。这些系统整合了来自整个生物製程工作流程中多个来源的数据，从而提供对製程性能的全面洞察。这使製造商能够在确保合规性的同时，实现更高的产品产量、降低批次间差异并最大限度地降低生产成本。然而，在预测期内，供应链营运管理预计将以16.5%的复合年增长率（CAGR）实现最高成长，这主要得益于全球生物製药企业日益认识到端到端可视性和协调的重要性。

预计到2025年，上游生物製程将占数位生物製造市场最大的占有率。这一主导地位源于其作为所有生物製造营运基础的根本作用，以及其对整体工艺经济性的显着影响。上游製程的最佳化尤其重要，因为它们直接影响产品的产量、品质和一致性。细胞培养製程的复杂性，包括pH值、溶解氧、温度、营养水平和代谢物浓度等众多相互依存的变量，为数位化优化创造了巨大的机会。先进的製程分析技术、即时监控系统和人工智慧驱动的控制演算法能够显着提高细胞生产力、降低污染风险并优化培养基消耗，从而促进数位化解决方案在上游生物製程的广泛应用。

预计2025年，单株抗体领域将占数位生物製造市场最大的占有率，达到33%。该领域占有率占比高主要归功于其完善的生产基础设施、成熟的生产流程以及产品本身巨大的商业价值。单株抗体复杂的多步骤生产流程（包括细胞系开发、上游细胞培养、下游纯化、製剂配製以及灌装包装等製程）为数位化优化提供了许多机会。单株抗体的高价值和大规模生产特性，促使企业对先进的数位技术进行大量投资，以提高产量、降低生产成本并确保产品品质的稳定性。然而，基因工程生物製剂领域预计将实现最快成长，在预测期内复合年增长率将达到17.9%。随着这些新兴疗法获得监管部门批准并取得商业成功，FDA预计到2025年每年将批准10至20种细胞和基因治疗产品。

预计到2025年，生物製药公司将占数位生物製造市场最大的占有率。对生物製药日益增长的偏好、个人化医疗研究的不断深入以及支持生物製药应用的政策，正在推动该领域占最大的市场占有率。由于生物製药通常较为复杂，且生产成本高于传统药物，生物製造业正扩大采用数位化解决方案来减少错误并扩大生产规模。生物製药公司数量的不断增长及其对数位技术的逐步采用，推动了该领域的领先地位，约55%的公司已在其工作流程中实施了数位技术。

本产业区域分析提供了对五大主要区域（北美、欧洲、亚太、拉丁美洲以及中东和非洲）及其各区域内主要国家的详细定性和定量见解。

预计到2025年，北美将占数位生物製造市场最大的占有率（38%）。该地区占有率庞大，得益于其拥有众多大型生物製药公司、先进的技术基础设施、大量的研发投资以及有利的监管环境。特别是美国，拥有众多生物技术中心，并在生物製剂的开发和生产方面保持领先地位。北美成熟的生物製药生态系统汇聚了许多拥有广泛生产网路、高度发展的供应链以及充足技术实施资金的大型公司。该地区的监管框架，以美国食品药物管理局 (FDA) 为首，一直积极推动先进製造技术的应用，并为生物製造领域的数位化技术提供指导。

然而，预计亚太地区在预测期内将实现最高的数位化生物製造市场复合年增长率 (CAGR)，达到 16.0%。这一成长主要得益于中国、印度、日本和韩国等国家生物製药产业的快速发展。该地区的成长动力来自政府对生物技术领域投资的增加、国内对生物製药需求的增长、生产能力的提升以及高性价比的合约研发生产机构 (CDMO) 的存在。此外，政府加大数位投入、对高性价比自动化解决方案的需求不断增长、生物製药生产基础设施的扩建以及人口稠密国家对营运效率的日益重视，都在推动市场扩张。该地区蓬勃发展的生物技术产业、不断扩大的研发活动、日益增长的熟练劳动力、生命科学领域不断增加的外国直接投资，以及支持数位技术的监管框架，正在为市场成长创造有利环境。

研究范围

按产品/服务划分的数位生物製造市场评估

  • 软体
    • 过程分析技术
    • 数据分析软体
    • 製造执行系统
    • 数位孪生平台
  • 硬体
  • 服务

按功能划分的数位生物製造市场评估

  • 产品设计
  • 过程最佳化与分析
  • 自动化与控制
  • 即时品质监控与合规性
  • 供应链与营运管理
  • 其他功能

按生物製程划分的数位生物製造市场评估

  • 上游生物工艺
  • 下游生物製程生物加工

数位生物製造市场评估：按应用领域划分

  • 单株抗体
  • 重组荷尔蒙/蛋白质
  • 疫苗
  • 细胞生物製品
  • 基因生物製品
  • 生物相似药
  • 工业生物技术
  • 其他应用

数位生物製造市场评估：按最终用户划分

  • 生物製药公司
  • 学术和研究机构
  • 合约研发生产力机构 (CDMO) 和合约研究组织 (CRO)
  • 食品和工业生物技术公司
  • 其他最终用户

数位生物製造市场评估：按地区划分

  • 北美
    • 美国美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞士
    • 丹麦
    • 爱尔兰
    • 比利时
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 其他亚太国家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非
    • 其他中东和非洲国家

表格内容

第一章：引言

第二章：研究方法

第三章：摘要整理

  • 细分市场分析
    • 依产品类型划分的市场分析
    • 依功能划分的市场分析
    • 依生物製程划分的市场分析
    • 按应用划分的市场分析
    • 依最终用户划分的市场分析
  • 地理分析
  • 竞争分析

第四章 市场洞察

  • 影响市场成长的因素
    • 驱动因素
      • 生物製药需求不断成长
      • 主要公司扩大生物製药厂产能
      • 对製程优化的需求不断成长
      • 对质量标准及法规遵守的关注度不断提高
      • 强大的生物製药研发管线
      • 日益重视连续生物工艺
    • 限制因素
      • 高昂的技术实施成本
      • 复杂的生物製药开发与生产工艺
    • 机遇
      • 工业4.0机遇
      • 先进资料分析工具的可用性
      • 向生物製程4.0转型
    • 挑战
      • 过程分析技术 (PAT) 实施的复杂性
    • 趋势
      • 人工智慧 (AI) 和机器学习的集成
      • 基于云端的製造平台
      • 先进的製程控制与自动化

第五章 数位化生物製造市场依产品/服务分类评估

  • 软体
    • 过程分析技术 (PAT)
    • 数据分析软体
    • 製造执行系统 (MES)
    • 数位孪生平台
  • 硬体
  • 服务

第六章：数位生物製造市场依功能分类评估

  • 产品设计
  • 过程最佳化与分析
  • 自动化与控制
  • 即时品质监控与合规
  • 供应链与营运管理
  • 其他（预测性维护、永续性仪表板）

第七章：数位生物製造市场依生物製程分类评估

  • 上游生物工艺
  • 下游生物製程生物加工

第八章：按最终用户划分的数位化生物製造市场评估

  • 单株抗体 (MAbs)
  • 重组荷尔蒙/蛋白质
  • 疫苗
  • 细胞生物製品
  • 基因生物製品
  • 生物相似药
  • 工业生物技术（酵素、生物基化学品、食品和饲料原料）
  • 其他（血液製品、胜肽和寡核苷酸）

第九章：按最终用户划分的数位化生物製造市场评估

  • 生物製药公司
  • 学术和研究机构
  • 合约研发生产力机构 (CDMO) 和合约研究组织 (CRO)
  • 食品和工业生物技术公司
  • 其他（政府实验室、联盟和非营利组织）

第十章：数位生物製造市场评估：按地区划分

  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 瑞士
    • 丹麦
    • 爱尔兰
    • 比利时
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 拉丁美洲美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区 (RoLATAM)
  • 中东和非洲

第11章 竞争格局

  • 关键成长策略
  • 竞争标竿分析
  • 竞争概览
    • 行业领导者
    • 市场差异化因素
    • 产业先锋
    • 新兴企业
  • 市占率/市场地位分析

第12章 公司简介

  • GE医疗科技公司
  • 西门子Xcelerator
  • Cytiva
  • ABB有限公司
  • 赛诺菲公司
  • 艾默生电气公司
  • 霍尼韦尔国际公司
  • SAP SE
  • Ovo Biomanufacturing Ltd.
  • 施耐德电机公司
  • 达梭系统公司
  • 甲骨文公司
  • 3M公司

第十三章：附录

Product Code: MRHC - 1041288

Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin] Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess - Global Forecast to 2035

According to the research report titled, 'Digital Biomanufacturing Market Size, Share, Forecast, & Trends Analysis by Offering (Software [PAT, MES, Digital Twin], Hardware), Functionality (Product Design, Analytics, Automation), Application (MAB, Protein, Vaccine), and Bioprocess-Global Forecast to 2035,' the digital biomanufacturing market is projected to reach $76.4 billion by 2035, at a CAGR of 12.6% during the forecast period 2025-2035. The report provides an in-depth analysis of the global digital biomanufacturing market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2035.

Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges. The growth of this market is driven by the escalating demand for biologics, capacity expansions of biopharmaceutical plants by key players, increased focus on continuous bioprocessing, rising need for process optimization in biomanufacturing, and the growing emphasis on quality standards and regulatory compliance. Moreover, the integration of artificial intelligence and machine learning, cloud-based manufacturing platforms, digital twin technology adoption, and the shift towards Bioprocessing 4.0 are expected to support the market's growth.

However, the market's growth faces notable challenges including the high cost of technology deployment, complex development and manufacturing processes of biopharmaceuticals, integration challenges with legacy systems, and concerns about data security and intellectual property protection.

The key players operating in the digital biomanufacturing market are GE Healthcare Technologies Inc. (U.S.), Siemens Xcelerator (subsidiary of Siemens) (Germany), Cytiva (subsidiary of Danaher Corporation) (U.S.), ABB Ltd. (Switzerland), Sanofi S.A. (France), Emerson Electric Co. (U.S.), Honeywell International, Inc. (U.S.), SAP SE (Germany), OVO Biomanufacturing Inc. (U.S.), Schneider Electric SE (France), Dassault Systemes (France), Oracle Corporation (U.S.), and 3M (U.S.).

The digital biomanufacturing market is segmented by offering (software and hardware), functionality (product design, process optimization & analytics, automation & control, real-time quality monitoring and compliance, supply chain and operations management, and other functionalities), bioprocess (upstream bioprocess and downstream bioprocess), application (monoclonal antibodies, recombinant hormones/proteins, vaccines, cellular-based biologics, gene-based biologics, biosimilars, industrial biotech, and other applications), end user (biopharmaceutical companies, academic and research institutes, CDMOs & CROs, food and industrial biotech companies, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

The software segment is projected to account for the largest market share of 58% in 2025. The dominance of this segment is primarily attributed to its fundamental role as the core intelligence layer driving process optimization, data analytics, and real-time decision-making across all biomanufacturing processes. This includes sophisticated process analytical technology (PAT) systems, advanced data analysis software, manufacturing execution systems (MES), and cutting-edge digital twin platforms that create virtual replicas of bioprocessing operations. The segment's growth is further accelerated by the continuous evolution of artificial intelligence and machine learning capabilities embedded within these platforms, transitioning from simple monitoring systems to intelligent platforms capable of predictive analytics, autonomous process adjustments, and cognitive decision-making. The software segment is also expected to register significant growth during the forecast period, driven by increasing adoption of cloud-based solutions and advanced analytics capabilities.

The process optimization & analytics segment is expected to dominate the digital biomanufacturing market in 2025. This segment's leadership reflects the critical need for continuous improvement in biomanufacturing processes, where even minor optimizations can result in significant cost savings, yield improvements, and quality enhancements. Process optimization & analytics encompasses advanced statistical process control, design of experiments (DoE), multivariate data analysis, and machine learning-powered optimization algorithms that continuously analyze process parameters to identify opportunities for improvement. These systems integrate data from multiple sources across the bioprocessing workflow to provide comprehensive insights into process performance, enabling manufacturers to achieve higher product yields, reduce batch-to-batch variability, and minimize production costs while maintaining regulatory compliance. However, the supply chain & operations management segment is projected to register the highest CAGR of 16.5% during the forecast period, driven by the increasing recognition of the importance of end-to-end visibility and coordination across global biopharmaceutical operations.

The upstream bioprocess segment is expected to account for the largest share of the digital biomanufacturing market in 2025. The upstream segment's dominance is due to its fundamental role as the foundation of all biomanufacturing operations and its significant impact on overall process economics. Upstream processes directly influence product yield, quality, and consistency, making optimization in this area particularly valuable. The complexity of cell culture processes, with their numerous interdependent variables including pH, dissolved oxygen, temperature, nutrient levels, and metabolite concentrations, creates substantial opportunities for digital optimization. Advanced process analytical technology, real-time monitoring systems, and AI-powered control algorithms can significantly improve cell productivity, reduce contamination risks, and optimize media consumption, driving the widespread adoption of digital solutions in upstream bioprocessing.

The monoclonal antibodies segment is expected to account for the largest share of 33% of the digital biomanufacturing market in 2025. The large share of this segment is attributed to the established manufacturing infrastructure, well-understood production processes, and significant commercial value of these products. The complex multi-step production process of monoclonal antibodies, involving cell line development, upstream cell culture, downstream purification, formulation, and fill-finish operations, creates numerous opportunities for digital optimization. The high value and large production volumes of monoclonal antibodies justify substantial investments in advanced digital technologies that can improve yields, reduce production costs, and ensure consistent product quality. However, the gene-based biologics segment is experiencing the fastest growth at a CAGR of 17.9% during the forecast period, as this emerging therapeutic modality gains regulatory approval and commercial traction, with the FDA anticipating approval of 10 to 20 cell and gene therapy products per year by 2025.

The biopharmaceutical companies segment is expected to account for the largest share of the digital biomanufacturing market in 2025. The increasing preference for biopharmaceuticals, growing research in personalized medicines, and supportive initiatives for the adoption of biopharmaceuticals are supporting the segment's largest market share. Biopharmaceuticals are typically complex and costlier than conventional drugs to manufacture, leading biomanufacturing industries to deploy digital solutions to reduce errors and scale up production processes. The increasing number of biopharmaceutical companies along with the gradually increasing adoption of digital technologies in these companies contributes to the segment's dominance, with approximately 55% of companies having incorporated digital technologies in their workflows.

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region.

North America is expected to account for the largest share of 38% of the digital biomanufacturing market in 2025. The large share of this region is attributed to the presence of leading biopharmaceutical companies, advanced technological infrastructure, substantial R&D investments, and a supportive regulatory environment. The United States, in particular, hosts numerous biotechnology hubs and maintains a leadership position in biologics development and manufacturing. North America's established biopharmaceutical ecosystem includes major companies with extensive manufacturing networks, well-developed supply chains, and significant financial resources for technology adoption. The region's regulatory framework, led by the FDA, has been progressive in encouraging the adoption of advanced manufacturing technologies and providing guidance on digital technologies in biomanufacturing.

However, Asia-Pacific is projected to register the highest CAGR of 16.0% during the forecast period across the overall digital biomanufacturing market. This growth is fueled by the rapidly expanding biopharmaceutical sectors in countries such as China, India, Japan, and South Korea. The region's growth is driven by increasing government investments in biotechnology, growing domestic demand for biologics, expanding manufacturing capacity, and the presence of cost-effective contract development and manufacturing organizations (CDMOs). Rising government initiatives aimed at digitization, growing demand for cost-effective automation solutions, expanding biopharmaceutical manufacturing infrastructure, and increasing focus on operational efficiency in densely populated countries are driving market expansion. The region's booming biotechnology sector, expanding research and development activities, growing skilled workforce, increasing foreign direct investments in the life sciences sector, and supportive regulatory frameworks for digital technology adoption are creating a conducive environment for market growth.

Key Questions Answered in the Report

  • What is the current revenue generated by the digital biomanufacturing market globally?
  • At what rate is the global digital biomanufacturing demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the global digital biomanufacturing market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of offering, functionality, bioprocess, application, and end user are expected to create major traction for the manufacturers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global digital biomanufacturing market?
  • Who are the major players in the global digital biomanufacturing market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the global digital biomanufacturing market? What are the impacts of these strategic developments on the market?

Scope of the Report

Digital Biomanufacturing Market Assessment-by Offering

  • Software
    • Process Analytical Technology
    • Data Analysis Software
    • Manufacturing Execution System
    • Digital Twin Platforms
  • Hardware
  • Services

Digital Biomanufacturing Market Assessment-by Functionality

  • Product Design
  • Process Optimization & Analytics
  • Automation & Control
  • Real-Time Quality Monitoring and Compliance
  • Supply Chain and Operations Management
  • Other Functionalities

Digital Biomanufacturing Market Assessment-by Bioprocess

  • Upstream Bioprocess
  • Downstream Bioprocess

Digital Biomanufacturing Market Assessment-by Application

  • Monoclonal Antibodies
  • Recombinant Hormones/Proteins
  • Vaccines
  • Cellular-based Biologics
  • Gene-based Biologics
  • Biosimilars
  • Industrial Biotech
  • Other Applications

Digital Biomanufacturing Market Assessment-by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutes
  • CDMOs & CROs
  • Food and Industrial Biotech Companies
  • Other End Users

Digital Biomanufacturing Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Denmark
    • Ireland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1 Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations

2 Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
    • 2.3.2. Bottom-Up Approach
    • 2.3.3. Top-Down Approach
    • 2.3.4. Growth forecast
  • 2.4. Assumptions for the Study

3 Executive Summary

  • 3.1. Overview
  • 3.2. Segmental Analysis
    • 3.2.1. Market Analysis, by Offering
    • 3.2.2. Market Analysis, by Functionality
    • 3.2.3. Market Analysis, by Bioprocess
    • 3.2.4. Market Analysis, by Application
    • 3.2.5. Market Analysis, by End-User
  • 3.3. Regional Analysis
  • 3.4. Competitive Analysis

4 Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1. Growing Demand for Biologics
      • 4.2.1.2. Capacity Expansions of Biopharmaceutical Plants by Key Players
      • 4.2.1.3. Increased Need for Process Optimization
      • 4.2.1.4. Increased Focus on Quality Standards & Regulatory Compliance
      • 4.2.1.5. Strong R&D Pipeline for Biopharmaceuticals
      • 4.2.1.6. Rising Focus on Continuous Bioprocessing
    • 4.2.2. Restraints
      • 4.2.2.1. High Cost of Technology Deployment
      • 4.2.2.2. Complex Development and Manufacturing Process of Biopharmaceuticals
    • 4.2.3. Opportunities
      • 4.2.3.1. Introduction of Industry 4.0
      • 4.2.3.2. Availability of Advanced Data Analysis Tools
      • 4.2.3.3. Shift Towards Bioprocessing 4.0
    • 4.2.4. Challenges
      • 4.2.4.1. Complexities In Process Analytical Technology (Pat) Implementation
    • 4.2.5. Trends
      • 4.2.5.1. Integration of Artificial Intelligence and Machine Learning
      • 4.2.5.2. Cloud-Based Manufacturing Platforms
      • 4.2.5.3. Advanced Process Control and Automation

5 Digital Biomanufacturing Market Assessment - by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. Process Analytical Technology (Pat)
    • 5.2.2. Data Analysis Software
    • 5.2.3. Manufacturing Execution System (Mes)
    • 5.2.4. Digital Twin Platforms
  • 5.3. Hardware
  • 5.4. Services

6 Digital Biomanufacturing Market Assessment - by Functionality

  • 6.1. Overview
  • 6.2. Product Design
  • 6.3. Process Optimization & Analytics
  • 6.4. Automation & Control
  • 6.5. Real-Time Quality Monitoring & Compliance
  • 6.6. Supply Chain & Operations Management
  • 6.7. Others (Predictive Maintenance, Sustainability Dashboards)

7 Digital Biomanufacturing Market Assessment - by Bioprocess

  • 7.1. Overview
  • 7.2. Upstream Bioprocessing
  • 7.3. Downstream Bioprocessing

8 Digital Biomanufacturing Market Assessment - by Application

  • 8.1. Overview
  • 8.2. Monoclonal Antibodies (Mabs)
  • 8.3. Recombinant Hormones/Proteins
  • 8.4. Vaccines
  • 8.5. Cellular-Based Biologics
  • 8.6. Gene-Based Biologics
  • 8.7. Biosimilars
  • 8.8. Industrial Biotech (Enzymes, Bio-Based Chemicals, Food & Feed Ingredients)
  • 8.9. Others (Blood Products, Peptides, Oligonucleotides)

9 Digital Biomanufacturing Market Assessment - by End-User

  • 9.1. Overview
  • 9.2. Biopharmaceutical Companies
  • 9.3. Academic and Research Institutes
  • 9.4. CDMOs & CROs
  • 9.5. Food & Industrial Biotech Companies
  • 9.6. Others (Government Labs, Consortia, and Non-Profit Organizations)

10 Digital Biomanufacturing Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Switzerland
    • 10.3.7. Denmark
    • 10.3.8. Ireland
    • 10.3.9. Belgium
    • 10.3.10. Rest of Europe (RoE)
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. South Korea
    • 10.4.5. Australia
    • 10.4.6. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America (RoLATAM)
  • 10.6. Middle East & Africa

11 Competitive Landscape

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share/Position Analysis

12 Company Profiles

  • 12.1. GE Healthcare Technologies, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Business Description
    • 12.1.3. Financial Overview
    • 12.1.4. Product Portfolio
    • 12.1.5. SWOT Analysis
  • 12.2. Siemens Xcelerator
    • 12.2.1. Company Overview
    • 12.2.2. Business Description
    • 12.2.3. Financial Overview
    • 12.2.4. Product Portfolio
    • 12.2.5. SWOT Analysis
  • 12.3. Cytiva
    • 12.3.1. Company Overview
    • 12.3.2. Business Description
    • 12.3.3. Financial Overview
    • 12.3.4. Product Portfolio
    • 12.3.5. SWOT Analysis
  • 12.4. ABB Ltd.
    • 12.4.1. Company Overview
    • 12.4.2. Business Description
    • 12.4.3. Financial Overview
    • 12.4.4. Product Portfolio
    • 12.4.5. SWOT Analysis
  • 12.5. Sanofi S.A.
    • 12.5.1. Company Overview
    • 12.5.2. Business Description
    • 12.5.3. Financial Overview
    • 12.5.4. Product Portfolio
    • 12.5.5. SWOT Analysis
  • 12.6. Emerson Electric Co.
    • 12.6.1. Company Overview
    • 12.6.2. Business Description
    • 12.6.3. Financial Overview
    • 12.6.4. Product Portfolio
    • 12.6.5. SWOT Analysis
  • 12.7. Honeywell International, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Business Description
    • 12.7.3. Financial Overview
    • 12.7.4. Product Portfolio
    • 12.7.5. SWOT Analysis
  • 12.8. SAP SE
    • 12.8.1. Company Overview
    • 12.8.2. Business Description
    • 12.8.3. Financial Overview
    • 12.8.4. Product Portfolio
    • 12.8.5. SWOT Analysis
  • 12.9. Ovo Biomanufacturing Ltd.
    • 12.9.1. Company Overview
    • 12.9.2. Business Description
    • 12.9.3. Financial Overview
    • 12.9.4. Product Portfolio
    • 12.9.5. SWOT Analysis
  • 12.10. Schneider Electric SE
    • 12.10.1. Company Overview
    • 12.10.2. Business Description
    • 12.10.3. Financial Overview
    • 12.10.4. Product Portfolio
    • 12.10.5. SWOT Analysis
  • 12.11. Dassault Systemes
    • 12.11.1. Company Overview
    • 12.11.2. Business Description
    • 12.11.3. Financial Overview
    • 12.11.4. Product Portfolio
    • 12.11.5. SWOT Analysis
  • 12.12. Oracle Corporation
    • 12.12.1. Company Overview
    • 12.12.2. Business Description
    • 12.12.3. Financial Overview
    • 12.12.4. Product Portfolio
    • 12.12.5. SWOT Analysis
  • 12.13. 3M
    • 12.13.1. Company Overview
    • 12.13.2. Business Description
    • 12.13.3. Financial Overview
    • 12.13.4. Product Portfolio
    • 12.13.5. SWOT Analysis

13 Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 2 Global Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 3 Global Digital Biomanufacturing Software Market, by Region/Country, 2023-2035 (USD Million)
  • Table 4 Global Process Analytical Technology (PAT) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 5 Global Data Analysis Software Market, by Region/Country, 2023-2035 (USD Million)
  • Table 6 Global Manufacturing Execution System (MES) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 7 Global Digital Twin Platforms Market, by Region/Country, 2023-2035 (USD Million)
  • Table 8 Global Digital Biomanufacturing Hardware Market, by Region/Country, 2023-2035 (USD Million)
  • Table 9 Global Digital Biomanufacturing Services Market, by Region/Country, 2023-2035 (USD Million)
  • Table 10 Global Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 11 Global Product Design Market, by Region/Country, 2023-2035 (USD Million)
  • Table 12 Global Process Optimization & Analytics Market, by Region/Country, 2023-2035 (USD Million)
  • Table 13 Global Automation & Control Market, by Region/Country, 2023-2035 (USD Million)
  • Table 14 Global Real-Time Quality Monitoring & Compliance Market, by Region/Country, 2023-2035 (USD Million)
  • Table 15 Global Supply Chain & Operations Management Market, by Region/Country, 2023-2035 (USD Million)
  • Table 16 Global Others (Predictive Maintenance, Sustainability Dashboards) Market, by Region/Country, 2023-2035 (USD Million)
  • Table 17 Global Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 18 Global Upstream Bioprocessing Market, by Region/Country, 2023-2035 (USD Million)
  • Table 19 Global Downstream Bioprocessing Market, by Region/Country, 2023-2035 (USD Million)
  • Table 20 Global Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 21 Global Digital Biomanufacturing Market for Monoclonal Antibodies (Mabs), by Region/Country, 2023-2035 (USD Million)
  • Table 22 Global Digital Biomanufacturing Market for Recombinant Hormones/Proteins, by Region/Country, 2023-2035 (USD Million)
  • Table 23 Global Digital Biomanufacturing Market for Vaccines, by Region/Country, 2023-2035 (USD Million)
  • Table 24 Global Digital Biomanufacturing Market for Cellular-Based Biologics, by Region/Country, 2023-2035 (USD Million)
  • Table 25 Global Digital Biomanufacturing Market for Gene-Based Biologics, by Region/Country, 2023-2035 (USD Million)
  • Table 26 Global Digital Biomanufacturing Market for Biosimilars, by Region/Country, 2023-2035 (USD Million)
  • Table 27 Global Digital Biomanufacturing Market for Industrial Biotech (Enzymes, Bio-Based Chemicals, Food & Feed Ingredients), by Region/Country, 2023-2035 (USD Million)
  • Table 28 Global Digital Biomanufacturing Market for Others (Blood Products, Peptides, Oligonucleotides), by Region/Country, 2023-2035 (USD Million)
  • Table 29 Global Digital Biomanufacturing Market, by End-User, 2023-2035 (USD Million)
  • Table 30 Global Digital Biomanufacturing Market for Biopharmaceutical Companies, by Region/Country, 2023-2035 (USD Million)
  • Table 31 Global Digital Biomanufacturing Market for Academic and Research Institutes, by Region/Country, 2023-2035 (USD Million)
  • Table 32 Global Digital Biomanufacturing Market for CDMOs & CROs, by Region/Country, 2023-2035 (USD Million)
  • Table 33 Global Digital Biomanufacturing Market for Food & Industrial Biotech Companies, by Region/Country, 2023-2035 (USD Million)
  • Table 34 Global Digital Biomanufacturing Market for Others (Government Labs, Consortia, and Non-Profit Organizations), by Region/Country, 2023-2035 (USD Million)
  • Table 35 North America: Digital Biomanufacturing Market, by Country, 2023-2035 (USD Million)
  • Table 36 North America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 37 North America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 38 North America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 39 North America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 40 North America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 41 North America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 42 U.S.: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 43 U.S.: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 44 U.S.: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 45 U.S.: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 46 U.S.: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 47 U.S.: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 48 Canada: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 49 Canada: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 50 Canada: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 51 Canada: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 52 Canada: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 53 Canada: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 54 Europe: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 55 Europe: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 56 Europe: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 57 Europe: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 58 Europe: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 59 Europe: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 60 Europe: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 61 Germany: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 62 Germany: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 63 Germany: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 64 Germany: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 65 Germany: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 66 Germany: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 67 France: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 68 France: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 69 France: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 70 France: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 71 France: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 72 France: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 73 U.K.: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 74 U.K.: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 75 U.K.: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 76 U.K.: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 77 U.K.: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 78 U.K.: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 79 Italy: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 80 Italy: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 81 Italy: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 82 Italy: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 83 Italy: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 84 Italy: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 85 Spain: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 86 Spain: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 87 Spain: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 88 Spain: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 89 Spain: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 90 Spain: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 91 Switzerland: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 92 Switzerland: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 93 Switzerland: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 94 Switzerland: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 95 Switzerland: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 96 Switzerland: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 97 Denmark: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 98 Denmark: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 99 Denmark: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 100 Denmark: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 101 Denmark: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 102 Denmark: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 103 Ireland: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 104 Ireland: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 105 Ireland: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 106 Ireland: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 107 Ireland: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 108 Ireland: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 109 Belgium: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 110 Belgium: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 111 Belgium: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 112 Belgium: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 113 Belgium: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 114 Belgium: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 115 Rest of Europe: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 116 Rest of Europe: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 117 Rest of Europe: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 118 Rest of Europe: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 119 Rest of Europe: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 120 Rest of Europe: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 121 Asia-Pacific: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 122 Asia-Pacific: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 123 Asia-Pacific: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 124 Asia-Pacific: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 125 Asia-Pacific: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 126 Asia-Pacific: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 127 Asia-Pacific: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 128 Japan: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 129 Japan: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 130 Japan: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 131 Japan: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 132 Japan: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 133 Japan: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 134 China: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 135 China: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 136 China: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 137 China: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 138 China: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 139 China: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 140 India: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 141 India: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 142 India: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 143 India: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 144 India: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 145 India: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 146 South Korea: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 147 South Korea: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 148 South Korea: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 149 South Korea: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 150 South Korea: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 151 South Korea: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 152 Australia: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 153 Australia: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 154 Australia: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 155 Australia: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 156 Australia: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 157 Australia: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 158 Rest of Asia Pacific: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 159 Rest of Asia Pacific: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 160 Rest of Asia Pacific: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 161 Rest of Asia Pacific: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 162 Rest of Asia Pacific: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 163 Rest of Asia Pacific: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 164 Latin America: Digital Biomanufacturing Market, by Country/Region, 2023-2035 (USD Million)
  • Table 165 Latin America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 166 Latin America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 167 Latin America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 168 Latin America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 169 Latin America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 170 Latin America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 171 Brazil: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 172 Brazil: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 173 Brazil: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 174 Brazil: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 175 Brazil: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 176 Brazil: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 177 Mexico: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 178 Mexico: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 179 Mexico: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 180 Mexico: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 181 Mexico: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 182 Mexico: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 183 Rest of Latin America: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 184 Rest of Latin America: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 185 Rest of Latin America: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 186 Rest of Latin America: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 187 Rest of Latin America: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 188 Rest of Latin America: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 189 Middle East & Africa: Digital Biomanufacturing Market, by Offering, 2023-2035 (USD Million)
  • Table 190 Middle East & Africa: Digital Biomanufacturing Software Market, by Type, 2023-2035 (USD Million)
  • Table 191 Middle East & Africa: Digital Biomanufacturing Market, by Functionality, 2023-2035 (USD Million)
  • Table 192 Middle East & Africa: Digital Biomanufacturing Market, by Bioprocess, 2023-2035 (USD Million)
  • Table 193 Middle East & Africa: Digital Biomanufacturing Market, by Application, 2023-2035 (USD Million)
  • Table 194 Middle East & Africa: Digital Biomanufacturing Market, by End User, 2023-2035 (USD Million)
  • Table 195 Number of Recent Developments, by Company, 2022-2025
  • Table 196 Key Strategic Developments, by Company, 2022-2025

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 In 2025, the Software Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 8 In 2025, the Process Optimization & Analytics Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 9 In 2025, the Upstream Bioprocessing Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 10 In 2025, the Monoclonal Antibodies Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 11 In 2025, the Biopharmaceutical Companies Segment is Expected to Dominate the Digital Biomanufacturing Market
  • Figure 12 Digital Biomanufacturing Market, by Region, 2025 Vs. 2032
  • Figure 13 Factors Affecting Market Growth
  • Figure 14 Global Digital Biomanufacturing Market, by Offering, 2025 Vs. 2035 (USD Million)
  • Figure 15 Global Digital Biomanufacturing Market, by Functionality, 2025 Vs. 2035 (USD Million)
  • Figure 16 Global Digital Biomanufacturing Market, by Bioprocess, 2025 Vs. 2035 (USD Million)
  • Figure 17 Global Digital Biomanufacturing Market, by Application, 2025 Vs. 2035 (USD Million)
  • Figure 18 Global Digital Biomanufacturing Market, by End-User, 2025 Vs. 2035 (USD Million)
  • Figure 19 Global Digital Biomanufacturing Market, by Region, 2025 Vs. 2035 (USD Million)
  • Figure 20 North America: Digital Biomanufacturing Market Snapshot
  • Figure 21 Europe: Digital Biomanufacturing Market Snapshot
  • Figure 22 Asia-Pacific: Digital Biomanufacturing Market Snapshot
  • Figure 23 Latin America: Digital Biomanufacturing Market Snapshot
  • Figure 24 Middle East & Africa: Digital Biomanufacturing Market Snapshot
  • Figure 25 Key Growth Strategies Adopted by Leading Players, 2022-2025
  • Figure 26 Digital Biomanufacturing Market: Competitive Benchmarking, by Region
  • Figure 27 Competitive Dashboard: Digital Biomanufacturing Market
  • Figure 28 Digital Biomanufacturing Market Position Analysis, 2024
  • Figure 29 SWOT Analysis - GE Healthcare Technologies, Inc.
  • Figure 30 SWOT Analysis - Siemens Xcelerator
  • Figure 31 SWOT Analysis - Cytiva
  • Figure 32 SWOT Analysis - ABB Ltd.
  • Figure 33 SWOT Analysis - Sanofi S.A.
  • Figure 34 SWOT Analysis - Emerson Electric Co.
  • Figure 35 SWOT Analysis - Honeywell International, Inc.
  • Figure 36 SWOT Analysis - SAP SE
  • Figure 37 SWOT Analysis - OVO Biomanufacturing Ltd.
  • Figure 38 SWOT Analysis - Schneider Electric SE
  • Figure 39 SWOT Analysis - Dassault Systemes
  • Figure 40 SWOT Analysis - Oracle Corporation
  • Figure 41 SWOT Analysis - 3M